Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris
Clinical trial NCT04163263 · COMPLETED
Trial details
- NCT number
- NCT04163263
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2020-11-11
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.